Day: May 8, 2020

Company Highlights:GAAP net loss of $59.3 million, or $0.54 per diluted common shareCore earnings of $40.7 million, or $0.31 per diluted common share1

MONACO, May 08, 2020 (GLOBE NEWSWIRE) — Navios Maritime Partners L.P. (“Navios Partners”) (NYSE: NMM) announced today that it will host a conference call on Wednesday, May 13, 2020 at 8:30 am ET, at which time Navios Partners’ senior management will provide highlights and commentary on earnings results for the first quarter ended March 31, 2020.The Company will announce earnings results for the first quarter ended March 31, 2020, prior to the conference call.A supplemental slide presentation will be available on the Navios Partners website at www.navios-mlp.com under the “Investors” section by 8:00 am ET on the day of the call.Conference Call details:Call Date/Time: Wednesday, May 13, 2020 at 8:30 am ETCall Title: Navios Partners Q1 2020 Financial Results Conference CallUS Dial In: +1.866.394.0817International...

Coronavirus interrupts solid start to yearInventory reduced by US$64.8 million in the quarter and a further reduction of US$68 million in AprilDorel Sports records fourth consecutive quarter of revenue growth; April bicycle sales surge as families seek exercise and alternatives to vacationsDorel Home’s revenue down 6.3%, e-commerce sales increased; April online sales of home products spikeDorel Juvenile hurt by pandemic, records a US$43.1 million non-cash impairment chargeMONTREAL, May 08, 2020 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) today released results for the first quarter ended March 31, 2020. Revenue was US$580.8 million, down 7.2% compared to US$625.6 million a year ago. Reported net loss was US$57.8 million, or US$1.78 per diluted share, compared to US$8.3 million or US$0.26 per diluted share last year....

Jersey City, N.J., May 08, 2020 (GLOBE NEWSWIRE) — Verisk (Nasdaq:VRSK), a leading data analytics provider, today announced that its 2020 Annual Meeting of Shareholders will be held as a live audio webcast rather than as an in-person event. Verisk is shifting to a virtual format as a precautionary measure for the health and well-being of employees, shareholders and the community in light of the COVID-19 pandemic. The virtual Annual Meeting will be held on Wednesday, May 20, 2020 at 4:00 p.m. E.T., instead of the previously announced time of 8:00 a.m. E.T. Shareholders and guests will not be able to attend in-person.Shareholders can join the audio web cast by visiting www.virtualshareholdermeeting.com/VRSK2020 and entering the 16-digit control number on their proxy card, voting instruction form or in their Notice of Internet Availability...

MELBOURNE, Australia, May 08, 2020 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has received ethics committee approval to commence a clinical trial to investigate early efficacy of Cynata’s proprietary Cymerus™ mesenchymal stem cells (MSCs) in adults admitted to intensive care with COVID-19. In addition, the Company also provides updated guidance on its wider clinical development pipeline.Key highlightsEthics approval received for clinical trial in patients in intensive care with COVID-19 in Australia: the MEND (MEseNchymal coviD-19) TrialCompromised lung function, which can ultimately progress to acute respiratory distress syndrome (ARDS), is a major complication in COVID-19 patientsThis...

FDA Approves New ICDs and CRT-Ds with Advanced Remote Capabilities DUBLIN, May 08, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced results from late-breaking clinical trials evaluating the MyCareLink Heart™ mobile app and the Micra® Transcatheter Pacing System (TPS), products that provide needed care for patients and optimal management of their symptoms – while reducing potential exposure between patients and their clinicians. During the current COVID-19 pandemic, procedures and therapies that reduce exposure to other people are important because that also reduces the potential for spreading the virus. The results were presented at the annual Heart Rhythm Society Scientific Sessions, held virtually for the first time.Results from the BlueSync™ Evaluation study demonstrated that patients who used the Medtronic MyCareLink...

Meets or exceeds 2020 sustainability commitments and on track for ambitious 2025 targetsBy end of 2019, 63% cocoa volume for chocolate brands sourced sustainably through Cocoa LifeConfirms 93% packaging designed to be recyclable; on-track to reach 100% by 2025CHICAGO, Ill., May 08, 2020 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (NASDAQ: MDLZ) today published its 2019 Snacking Made Right Report, highlighting the company’s significant progress towards achieving its 2025 sustainable and mindful snacking goals. The report outlines Mondelēz International’s ongoing commitment to lead the future of snacking by leveraging its global scale to deliver positive change.The Snacking Made Right report includes Mondelēz International’s signature sustainable sourcing programs and approaches driven by the company’s purpose – to empower people...

Tebipenem HBr Phase 3 trial enrollment complete with top-line data expected in the third quarter of 2020SPR720 Phase 2a NTM trial initiation planned for the second half of 2020Conference call and live webcast at 10:00 a.m. EDT todayCAMBRIDGE, Mass., May 08, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced financial results for the first quarter ended March 31, 2020 and provided a business update.“We have made significant progress to date in 2020 in advancing our pipeline of drug candidates for serious unmet needs and multi-drug resistant infections,” said Ankit Mahadevia, M.D., Chief...

HOUSTON, May 08, 2020 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET, the “Company”), a leading provider of ultra-secure, intelligent networking solutions and specialized applications, announced its results for the quarter ended March 31, 2020.First quarter 2020 revenue of $58.8 million, net loss of $26.8 million or $1.34 per shareRevenue increased 2.2% to $58.8 million year-over-year; declined 8.3% compared to prior quarterQuarterly results included a non-cash impairment of goodwill of $23.1 million or $1.15 per shareAdjusted EBITDA of $8.4 million essentially flat with $8.4 million in the prior year quarter; declined 30% compared to prior quarterIncreased Managed Communications Services (MCS) Sites served to 1,351, or 0.8% compared to the prior quarter; sites declined by 0.7% compared to the prior year quarterProject backlog of...